Portola Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Portola Pharmaceuticals Ownership

Who owns Portola Pharmaceuticals?

Portola Pharmaceuticals is owned by Alexion Pharmaceuticals. It was acquired on May 5, 2020.

Was Portola Pharmaceuticals formerly PE-backed?

Yes. Portola Pharmaceuticals was formerly owned by 1 private investor.

Portola Pharmaceuticals Business Overview

Where is Portola Pharmaceuticals headquartered?

Portola Pharmaceuticals is headquartered in South San Francisco, California.

What is Portola Pharmaceuticals’ revenue?

Portola Pharmaceuticals disclosed revenue of 117M USD for 2019 and 40M USD for 2018.

How many employees does Portola Pharmaceuticals have?

Portola Pharmaceuticals has 324 employees.

What sector is Portola Pharmaceuticals in?

Portola Pharmaceuticals is a life science company.

When was Portola Pharmaceuticals founded?

Portola Pharmaceuticals was founded in 2003.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 282 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 259 by strategics.

Portola Pharmaceuticals, Inc.

270 East Grand Avenue,
South San Francisco, California 94080
United States,
(650) 246-7000
www.portola.com

Portola Pharmaceuticals, Inc. is a biopharmaceutical company, discovers and develops therapeutics for cardiovascular and autoimmune diseases. Portola Pharmaceuticals was founded in 2003 and is based in South San Francisco, California.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.